Skip to search formSkip to main contentSkip to account menu

buflomedil

Known as: 2,4,6-trimethoxyphenyl-3-pyrrolidine propyl ketone, blufomedil, 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
A 15-year-old girl was admitted to ICU in a comatose state. She presented with mydriasis, areflexia, hypoxemia and seizures. She… 
2001
2001
BACKGROUND Changes in blood rheology have been described in diabetes mellitus. Buflomedil, a vasoactive substance with… 
1995
1995
Summary— A meta‐analysis was performed on the results of clinical trials of buflomedil in intermittent claudication. The analysis… 
1992
1992
A life-threatening intoxication, requiring ventilatory support, is reported from the ingestion of 3.05 g of buflomedil, a… 
1991
1991
The effect of buflomedil on postischemic reperfusion injury was studied in the dorsal skin fold chamber preparation of awake… 
1990
1990
1 Blood flow (measured by radio‐labelled microspheres), fibre composition and capillary/fibre ratio were estimated in rat fast… 
1989
1989
Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the release and uptake of… 
1984
1984
Buflomedil hydrochloride, 4-(l-pyrolidiny)-1-(2,4,6-trimethoxyphenyl)-lbutanone hydrochloride, is a recently introduced… 
1981
1981
This brief communication outlines re cent experiments on the effects of buflo medil, a new vasoactive agent, on red cell…